← Leaderboards
Gabrielle Fredman
Columbia University Health Sciences
$6,989,319
Attributed
$8,177,613
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2013–25$2M$1.5M$1M$500K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,177,613 · 5
By mechanism
R01$7,230,232 · 3
R00$731,381 · 1
K99$216,000 · 1
Top collaborators
- Katherine C. Macnamara3 shared
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Vadim S Ten$8,673,722
- Elaine Janine Abrams$67,853,604
- Benjamin Landon Myer$8,501,100
- Robert A Whittington$3,133,147
- Ira A Tabas$44,847,082
Others in their field
Top investigators on “Signal Transduction”
- Peter B. Gilbert · Fred Hutchinson Cancer Center$148,539,615
- David Heimbrook · Leidos Biomedical Research, Inc.$82,049,940
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$70,290,471
- Garret A Fitzgerald · University Of Pennsylvania$66,142,222
- Michael Barry Kastan · Duke University$64,512,357
- Randall J Bateman · Washington University$62,939,456
Research focus
Signal TransductionDriving ForcePhenotypeInflammatoryCause Of DeathCellsInflammationProgramsAtherosclerosisResolutionEquilibriumLeukotrienesCardiovascular DiseasesNecrosisTreatment StrategyChronicLipoxinsInflammatory ResponseSignal PathwayIn VivoEnzymesAreaMediator Of Activation ProteinInsight
Grant awards (20)
Inflammation-resolution impairments in aging and atherosclerosis$795,777
R01 · FY2025 · HL · contact PI
Inflammation-resolution impairments in aging and atherosclerosis$778,674
R01 · FY2024 · HL · contact PI
Inflammation-resolution impairments in aging and atherosclerosis$802,138
R01 · FY2023 · HL · contact PI
Senescence dysregulates of inflammation-resolution programs in atherosclerosis$617,817
R01 · FY2023 · HL · contact PI
Senescence dysregulates of inflammation-resolution programs in atherosclerosis$52,160
R01 · FY2023 · HL · contact PI
Senescence dysregulates of inflammation-resolution programs in atherosclerosis$617,817
R01 · FY2022 · HL · contact PI
Necroptosis Impairs Inflammation-Resolution Programs in Atherosclerosis$427,622
R01 · FY2022 · HL · contact PI
Senescence dysregulates of inflammation-resolution programs in atherosclerosis$52,160
R01 · FY2022 · HL · contact PI
Senescence dysregulates of inflammation-resolution programs in atherosclerosis$617,817
R01 · FY2021 · HL · contact PI
Necroptosis Impairs Inflammation-Resolution Programs in Atherosclerosis$432,897
R01 · FY2021 · HL · contact PI
Senescence dysregulates of inflammation-resolution programs in atherosclerosis$48,357
R01 · FY2021 · HL · contact PI
Senescence dysregulates of inflammation-resolution programs in atherosclerosis$642,668
R01 · FY2020 · HL · contact PI
Necroptosis Impairs Inflammation-Resolution Programs in Atherosclerosis$438,018
R01 · FY2020 · HL · contact PI
Necroptosis Impairs Inflammation-Resolution Programs in Atherosclerosis$442,991
R01 · FY2019 · HL · contact PI
Necroptosis Impairs Inflammation-Resolution Programs in Atherosclerosis$463,319
R01 · FY2018 · HL · contact PI
Specialized pro-resolving mediators in atherosclerosis$238,536
R00 · FY2017 · HL · contact PI
Specialized pro-resolving mediators in atherosclerosis$243,845
R00 · FY2016 · HL · contact PI
Specialized pro-resolving mediators in atherosclerosis$249,000
R00 · FY2015 · HL · contact PI
Specialized pro-resolving mediators in atherosclerosis$108,000
K99 · FY2014 · HL · contact PI
Specialized pro-resolving mediators in atherosclerosis$108,000
K99 · FY2013 · HL · contact PI